Viewing Study NCT01435395


Ignite Creation Date: 2025-12-24 @ 2:16 PM
Ignite Modification Date: 2026-01-11 @ 7:16 AM
Study NCT ID: NCT01435395
Status: COMPLETED
Last Update Posted: 2016-04-27
First Post: 2011-09-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme
Sponsor: Emory University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module